Improving antibody affinity through <i>in vitro</i> mutagenesis in complementarity determining regions-Reference-Cited by-同舟云学术

Improving antibody affinity through <i>in vitro</i> mutagenesis in complementarity determining regions

Published:2022 Issue:3 Volume:36 Page:155
ISSN:1674-8301
Container-title:The Journal of Biomedical Research
language:
Short-container-title:J Biomed Res

Author:

Ye Wei,Liu Xiaoyu,He Ruiting,Gou Liming,Lu Ming,Yang Gang,Wen Jiaqi,Wang Xufei,Liu Fang,Ma Sujuan,Qian Weifeng,Jia Shaochang,Ding Tong,Sun Luan,Gao Wei

Publisher

Journal of Biomedical Research

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.jbr-pub.org.cn/fileSWYXYJZZYWB/journal/article/swyxyjzzywb/2022/3/JBR-2022-0003.pdf

Reference40 articles.

1. Basu K, Green EM, Cheng Y, et al. Why recombinant antibodies—benefits and applications[J]. Curr Opin Biotechnol, 2019, 60: 153–158.

2. Lu RM, Hwang YC, Liu IJ, et al. Development of therapeutic antibodies for the treatment of diseases[J]. J Biomed Sci, 2020, 27(1): 1.

3. Urquhart L. Top companies and drugs by sales in 2020[J]. Nat Rev Drug Discov, 2021, 20(4): 253.

4. Smith GP. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface[J]. Science, 1985, 228(4705): 1315–1317.

5. Lerner RA, Kang AS, Bain JD, et al. Antibodies without immunization[J]. Science, 1992, 258(5086): 1313–1314.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review of in vitro stochastic and non-stochastic affinity maturation strategies for phage display derived monoclonal antibodies;International Journal of Biological Macromolecules;2024-10

2. An in silico investigation on the binding site preference of PD-1 and PD-L1 for designing antibodies for targeted cancer therapy;PLOS ONE;2024-07-25

3. Design and Production of a Novel Anti-PD-1 Nanobody by CDR Grafting and Site-Directed Mutagenesis Approach;Molecular Biotechnology;2024-05-12

4. Binding affinity optimization and structural evaluation of designed antibodies against PD-1 and PD-L1 as critical immune checkpoints involved in cancer treatment;2024-01-11

5. Improving the cytotoxicity of immunotoxins by reducing the affinity of the antibody in acidic pH;Journal of Translational Medicine;2023-08-25